Backbone cyclization of the C-terminal part of substance P. Part 1: The important role of the sulphur in position 11

Journal of Peptide Science

Volumn 2, Issue 4, 1996, Pages 261-269

  Bitan, Gal ^a   Zeltser, Irena ^a   Byk, Gerardo ^a   Halle, David ^a   Mashriki, Yaffa ^b   Gluhov, Evgenia V ^a   Sukhotinsky, Inna ^a   Hanani, Menachem ^b   Selinger, Zvi ^a   Gilon, Chaim ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Agonist; Backbone cyclization; Conformational constraint; Substance P

Indexed keywords

CYCLOPEPTIDE; DRUG DERIVATIVE; NEUROKININ 1 RECEPTOR; NEUROKININ 2 RECEPTOR; NEUROKININ 3 RECEPTOR; SUBSTANCE P; SULFUR;

ANIMAL; ARTICLE; BIOASSAY; CHEMISTRY; CYCLIZATION; DRUG EFFECT; GUINEA PIG; ILEUM; METABOLISM; PHYSIOLOGY; SYNTHESIS;

ANIMALS; BIOLOGICAL ASSAY; CYCLIZATION; GUINEA PIGS; ILEUM; PEPTIDES, CYCLIC; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-2; RECEPTORS, NEUROKININ-3; SUBSTANCE P; SULFUR;

EID: 0030178429     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1387(199607)2:4<261::AID-PSC76>3.0.CO;2-T     Document Type: Article

References (48)

1. Y. Ovchinikov, G. Chipens and V. Ivanov, in: Peptides 1982, K. Bláha and P. Malon, Eds., p. 1-18, de Gruyter, Berlin 1983.
2. C. Gilon, D. Halle, M. Chorev, Z. Selinger and G. Byk (1991). Backbone cyclizatlon: A new method for conferring conformational constraint on peptides. Biopolymers 31, 745-750.
3. C. Gilon, I. Zeltser, V. Rashti-Behar, D. Muller, G. Bitan, D. Halle, G. Bar-Akiva, Z. Selinger and G. Byk, in: Peptide Chemistry 1992, N. Yanaihara, Ed., p. 482-485, ESCOM Science Publishers B.V., Leiden 1993.
4. G. Byk and C. Gilon (1992). Building units for N-backbone cyclic peptides. 1. Synthesis of protected N-(ω-aminoalkyl) amino acids and their incorporation into dipeptide units. J. Org. Chem. 57, 5687-5691.
5. α-(ω-thioalkyl)amino acids and their incorporation into dipeptide units. Tetrahedron 51, 10513-10522.
6. α- (ω-carboxyalkyl)amino acids. Submitted to Tetrahedron.
7. C. Gilon, I. Zeltser, D. Muller, G. Bitan, D. Eren and A. Seri-Levi (1994). Israeli Patent Application no. 109943; International Patent Application no. PCT/IB95/00453.
8. D. Regoli, A. Boudon and J.-L. Fouchere (1994). Receptors and antagonists for substance P and related peptides. Pharmacol. Rev. 46, 551-559.
9. R. Laufer, U. Wormser, Z. Y. Friedman, C. Gilon, M. Chorev and Z. Selinger (1985). Neurokinin B is a preferred agonist for neuronal substance P receptor and its action is antagonized by enkephalin. Proc. Natl Acad. Sci. USA 83, 7444-7448.
10. U. Wormser, R. Laufer, Y. Hart, M. Chorev, C. Gilon and Z. Selinger (1986). Highly selective agonists for substance P receptor subtypes. EMBO J. 5, 2805-2808.
11. R. Laufer, C. Gilon, M. Chorev and Z. Selinger (1986). Characterization of a neurokinin B receptor site in rat brain using a highly selective radioligand. J. Biol. Chem. 261, 10257-10263.
12. R. Laufer, C. Gilon, M. Chorev and Z. Selinger (1986). Desensitization with a selective agonist discriminates between multiple tachykinin receptors. Pharmacol. Exp. Ther. 245, 639-643.
13. S. P. Watson, B. E. F. Sandberg, M. R. Hanley and L. L. Iversen (1983). Tissue selectivity of substance P alkylesters suggesting multiple receptors. Eur. J. Pharmacol. 87, 77-84.
14. B. E. Sandberg, C. M. Lee, M. R. Hanley and L. L. Iversen (1981). Synthesis and biological properties of enzyme resistant substance P analogues. Eur. J. Biochem. 114, 329-337.
15. G. Dupreau, P. D'Orleans-Juste, S. Dion, N. E. Rhaleb and D. Regoli (1987). Specific agonists for neurokinin B receptors. Eur. J. Pharmacol. 136, 401-403.
16. P. Rovero, V. Pestellini, R. Patacchini, S. Giuliani, P. Santicioli, C. A. Maggi, A. Meli and A. Giachetti (1989). A potent and selective agonist for the NK-2 tachykinin receptor. Peptides 10, 593-595.
17. M. J. Deal, R. M. Hagan, S. J. Ireland, C. C. Jordan, A. B. McElroy, B. Porter, B. C. Ross, M. Stephens-Smith and P. Ward (1992). Conformationally constrained tachykinin analogues: Potent and highly selective NK-2 receptor agonists. J. Med. Chem. 35, 4195-4204.
18. C. Poulos, G. Stavropoulos, J. R. Brown and C. C. Jordan (1987). Structure-activity studies on the C-terminal hexapeptide of substance P with modifications at the glutaminyl and methionyl residues. J. Med. Chem. 30, 1512-1515.
19. 11 with Glu(OBzl) and N-terminal glutamine with Glp of the C-terminal hexapeptide and heptapeptide of substance P. Int. J. Peptide Protein Res. 45, 508-513.
20. 1) receptor. Science 251, 435-437.
21. M. C. Desai, S. L. Lefkowitz, P. F. Thadeio, K. P. Longo and R. M. Snider (1992). Discovery of a potent substance P antagonist: Recognition of the key molecular determinant. J. Med. Chem. 35, 4911-4913.
22. C. Garret, A. Carruette, V. Fardin, S. Moussaoui, J. Peyronel, J. Blanchard and P. Laduron (1992). Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proc. Natl Acad. Sci. USA 88, 10208-10212.
23. 1 antagonists derived from L-tryptophane. J. Med. Chem. 38, 934-941.
24. F. Oury-Donat, I. A. Lefevre, T. Gautier, X. Edmonds-Alt, G. Le Fur and P. Soubrie (1994). SR 140333, a novel and potent antagonist of the NK1 receptor characterization on the U373MG cell line. Neuropeptides 24, 233.
25. R. Hirschmann, K. C. Nicolaou, S. Pietranico, J. Salvino, E. M. Leahy, P. A. Sprengeler, G. Furst, A. B. Smith III, C. D. Strader, M. A. Cascieri, M. R. Candelore, C. Donaldson, W. Vale and L. Maechler (1992). Nonpeptide peptidomimetics with a β-D-glucose scaffolding. A partial somatostatin agonist bearing a close structural relationship to a potent, selective substance P antagonist. J. Am. Chem. Soc. 114, 9217-9218.
26. 1 receptor for substance P and a non-peptide antagonist. Nature 362, 345-348.
27. T. M. Fong, M. A. Cascieri, H. Yu, A. Bansal, C. Swain and C. D. Strader (1993). Amino-aromatic interaction between histidine 197 of the neurokinin-1 receptor and CP 96345. Nature 362, 350-353.
28. P. Manavalan and F. A. Momany (1982). Conformational energy calculations on substance P. Int. J. Peptide Protein Res. 20, 351-356.
29. G. Chassaing, O. Convert and S. Laville (1986). Preferential conformation of substance P in solution. Eur. J. Biochem. 154, 77-85.
30. J. K. Young, C. Anklin and R. P. Hicks (1994). NMR and molecular modeling investigations of the neuropeptide substance P in the presence of 15 mM sodium dodecyl sulfate micelles. Biopolymers 34, 1449-1462.
31. 6-11 hexapeptide. Pharmazie 40, 456-459.
32. 6-11 hexapeptide. Pharmazie 40, 532-535.
33. G. Chassaing, S. Lavielle, O. Ploux, S. Julien, O. Convert, A. Marquet, J. C. Beaujouan, Y. Torrens and J. Glowinski in: Peptides 1984, U. Ragnarsson, Ed., p. 345-348, Almquist & Wiksell, Stockholm 1985.
34. D. Theodoropoulos, C. Poulos, D. Gatos, P. Cordopatis, E. Escher, J. Mizrahi, D. Regoli, D. Dalietos, A. Furst and T. D. Lee (1985). Conformationally restricted C-terminal peptides of substance P. Synthesis, mass spectral analysis and pharmacological properties. J. Med. Chem. 28, 1536-1539.
35. P. S. Darman, G. C. Landis, J. R. Smits, L. D. Hirning, K. Gulya, H. I. Yamamura, T. F. Burks and V. J. Hruby (1985). Conformationally restricted cyclic analogues of substance P: Insight into the receptor binding process. Biochem. Biophys. Res. Commun. 127, 656-662.
36. G. Byk, D. Halle, I. Zeltser, G. Bitan, Z. Selinger and C. Gilon. Synthesis and biological activity of NK-1 selective, N-backbone cyclic analogues of the C-terminal hexapeptide of substance P. J. Med. Chem., in press
37. J. Saulitis, D. F. Mierke, G. Byk, C. Gilon and H. Kessler (1992). Conformation of cyclic analogues of substance P: NMR and molecular dynamics in dimethyl sulfoxide. J. Am. Chem. Soc. 114, 4818-4827.
38. S. Golic Grdadolnik, D. Mierke, G. Byk, I. Zeltser, C. Gilon and H. Kessler (1994). Comparison of the conformation of active and nonactive backbone cyclic analogues of substance P as a tool to elucidate features of the bioactive conformation: NMR and molecular dynamics in DMSO and water. J. Med. Chem. 37, 2145-2152.
39. G. Bitan, S. Behrens, B. Mathä, Y. Mashriki, M. Hanani, H. Kessler and C. Gilon (1995). New backbone cyclic substance P analogues. Lett. Peptide Sci. 2, 121-124.
40. S. Zacharia, W. J. Rossowski, N.-Y. Jiang, P. Hibas, A. Ertan and D. H. Coy (1991). New reduced peptide bond substance P agonists and antagonists: Effects on smooth muscle contraction. Eur. J. Pharmacol. 203, 353-357.
41. C. Poulos, G. Stavropoulos, J. R. Brown and C. C. Jordan (1987). Structure-activity studies on the C-terminal hexapeptide of substance P with modifications at the glutaminyl and methionyl residues. J. Med. Chem. 30, 1512-1515.
42. R. Schwyzer (1992). How do peptides interact with lipid membranes and how does this affect their biological activity? Brazilian J. Med. Biol. Res. 25, 1077-1089.
43. K. Karagiannis, A. Manolopoulou, G. Stavropoulos, C. Poulos, C. C. Jordan and R. M. Hagan (1991). Synthesis of a potent agonist of substance P by modifying the methionyl and glutaminyl residues of the C-terminal hexapeptide of substance P. Int. J. Peptide Protein Res. 38, 350-356.
44. 6-11 by benzyl ester groups. Int. J. Peptide Protein Res. 42, 565-569.
45. P. E. Thompson, H. H. Keah, P. T. Gomme, P. G. Stanton and M. T. W. Hearn (1995). Synthesis of peptide amides using Fmoc-based solid-phase procedures on 4-methyl-benzhydrylamine resins. Int. J. Peptide Protein Res. 46, 174-180.
46. C. Gilon, G. Bitan and D. Muller, in press.
47. R. A. Houghten (1985). General method for the rapid solid-phase synthesis of peptides: Specificity of antigen-antibody interaction at the level of individual amino acids. Proc. Natl Acad. Sci. USA 82, 5131-5135.
48. S. Zimmer, E. Hoffmann, G. Jung and H. Kessler in: Peptides 1992, C. H. Schneider and A. N. Eberle, Eds., p. 393-394, ESCOM Science Publishers BV 1993.